Re-branding of imported medicines under EU court spotlight
Parallel importers risk trade mark infringement if they seek to sell packets of generic medicines imported from one EU country to another under brand names for reference products developed by the same manufacturer, a senior legal adviser to the EU’s highest court has said.
